Executive Summary: Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
Peter G. Pappas(University of Alabama at Birmingham), Jack D. Sobel(Wayne State University), David R. Andes(University of Wisconsin–Madison), Luis Ostrosky‐Zeichner(The University of Texas Health Science Center), Kieren A. Marr(Freedom to Live), Thomas J. Walsh(Cornell University), Annette C. Reboli(Cooper Medical School of Rowan University), Theoklis E. Zaoutis(Radboud University Medical Center), José A. Vázquez(Augusta University), Cornelius J. Clancy(University of Pittsburgh), Carol A. Kauffman(University of Michigan), Mindy G. Schuster(Unknown)
Cited by 1,283
Related Papers
Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
|Clinical Infectious Diseases|2008|4.9k
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2015|4k
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
|New England Journal of Medicine|2002|3.3k
Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2009|3.2k
Epidemiology and Outcome of Zygomycosis: A Review of 929 Reported Cases
|Clinical Infectious Diseases|2005|3k